In vitro immunologic properties of human umbilical cord perivascular cells

References

• Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23: 220–9
   PubMed Web of Science ®Google Scholar
• da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204–13
   PubMed Web of Science ®Google Scholar
• Shi, S, Gronthos, S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003;18:696–704.
   PubMed Web of Science ®Google Scholar
• McElreavey, KD, Irvine, AI, Ennis, KT, McLean, WH. Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord. Biochem Soc Trans 1991;19:29S.
   Web of Science ®Google Scholar
• Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003; 21: 50–60
   PubMed Web of Science ®Google Scholar
• Medicetty S, Bledsoe AR, Fahrenholtz CB, et al. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Exp Neurol 2004; 190: 32–41
   PubMed Web of Science ®Google Scholar
• Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2005; 24: 781–792
   PubMed Web of Science ®Google Scholar
• Weiss ML, Mitchell KE, Hix JE, et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003; 182: 288–99
   PubMed Web of Science ®Google Scholar
• Naughton, B, San Roman, J, Liu, K, , et al. Cells isolated from Wharton's jelly of the human umbilical cord develop a cartilage phenotype when treated with TGF-beta in vitro. FASEB J 1997;11:A19.
   PubMed Web of Science ®Google Scholar
• Bailey MM, Wang L, Bode CJ, et al. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007; 13: 2003–10
   PubMedGoogle Scholar
• Conconi MT, Burra P, Di LR, et al. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006; 18: 1089–96
   PubMed Web of Science ®Google Scholar
• Schmidt D, Mol A, Odermatt B, et al. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng 2006; 12: 3223–32
   PubMedGoogle Scholar
• Ennis J. Human Umbilical Cord Perivascular Cells (HUCPVCs): Verification of their Provenance and Immunocharacterization. Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto 2006
   Google Scholar
• Baksh D, Yao R, Tuan R. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 45: 99–106
   Google Scholar
• Gomez-Aristizabal, A, Hanoun, L, Sarugaser, R, Davies, J. Human Umbilical Cord Perivascular Cells (HUCPVCs) Display High Proliferative Capacity but no Telomerase Activity. International Society for Stem Cell Research, Deerfield, IL 2006.
   Google Scholar
• Sarugaser R, Hanoun L, Kwong F, et al. Human Umbilical Cord Perivascular Cell (HUCPVC) Clones Determine Mesenchymal Stem Cell Identity. International Society for Stem Cell Research, Deerfield, IL 2006
   Google Scholar
• Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006; 36: 2566–73
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321–34
   PubMed Web of Science ®Google Scholar
• Tse W, Pendleton J, Beyer W, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–97
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890–6
   PubMed Web of Science ®Google Scholar
• Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875–84
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5: 485–9
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–43
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–8
   PubMed Web of Science ®Google Scholar
• Beggs KJ, Lyubimov A, Borneman JN, et al. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 2006; 15: 711–21
   PubMed Web of Science ®Google Scholar
• Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755–61
   PubMed Web of Science ®Google Scholar
• Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407–11
   PubMed Web of Science ®Google Scholar
• Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289: F31–42
   PubMed Web of Science ®Google Scholar
• Ringden, O, Uzunel, M, Rasmusson, I, , et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;1390–7.
   PubMedGoogle Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet 2004; 363: 1439–41
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294–301
   PubMed Web of Science ®Google Scholar
• Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919–26
   PubMed Web of Science ®Google Scholar
• Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24: 376–85
   PubMed Web of Science ®Google Scholar
• Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118–29
   PubMed Web of Science ®Google Scholar
• Marshall A. Vertebrate Embryology. Smith Elder and Co., London 1893
   Google Scholar
• Naeye RL. Umbilical cord length: clinical significance. J Pediatr 1985; 107: 278–81
   PubMed Web of Science ®Google Scholar
• Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330–7
   PubMed Web of Science ®Google Scholar
• Bruder SP, Jaiswal N, Ricalton NS, et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998; 355(Suppl)S247–56
   Google Scholar
• Taupin P. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs 2006; 7: 473–81
   PubMedGoogle Scholar
• Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279–95
   PubMed Web of Science ®Google Scholar
• Kalman L, Lindegren ML, Kobrynski, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med 2004; 6: 16–26
   PubMed Web of Science ®Google Scholar
• Huntington ND, Tarlington DM. CD45: direct and indirect government of immune regulation. Immunol Lett 2004; 94: 167–74
   PubMed Web of Science ®Google Scholar
• Dawes, R, Petrova, S, Liu, Z, , et al. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol 2006; 176: 3417–25.
   PubMed Web of Science ®Google Scholar
• McNeill L, Salmon RJ, Cooper JC, et al. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity 2007; 27: 425–37
   Google Scholar